When is tumour removal surgery recommended for neuroblastoma?

Neuroblastoma often develops near the adrenal glands, spine or major blood vessels. Imaging, biopsy findings and risk assessment show how far it extends and whether it surrounds structures that should not be disturbed. For some children, medicines are given first to shrink the tumour or control disease before an operation. Surgery may then remove the remaining primary tumour or reduce its bulk.

The aim is not always to remove every visible cell if doing so could damage an important nerve, organ or vessel. The plan may include chemotherapy, radiotherapy, stem-cell treatment or targeted medicines, depending on the child’s risk group and response. Paediatric cancer and surgical teams make the decision together.

Ask the team to explain the scan findings, the intended amount of removal and the reason for the proposed timing. Share your child’s medicines, allergies and previous procedures. Discuss pain control, hospital recovery, nutrition, activity limits and the possible need for further treatment. A written plan can help coordinate appointments across oncology, surgery and supportive care.

Seek prompt assessment for a growing abdominal or neck swelling, persistent bone pain, weakness, unexplained bruising, breathing difficulty or changes in bladder or bowel control. After surgery, contact the hospital for fever, wound redness, repeated vomiting, increasing abdominal swelling, reduced urine or uncontrolled pain. New leg weakness or difficulty breathing requires emergency care.

Is surgery planned before or after medicines? Which structures are close to the tumour? Is the goal complete removal or safe reduction? What symptoms could indicate nerve, bowel, bladder or blood-vessel effects?